Ethnic differences in mortality, end-stage complications, and quality of care among diabetic patients: a review

…, JP Mackenbach, SWJ Lamberts, AH Bootsma - Diabetes …, 2005 - Am Diabetes Assoc
OBJECTIVE—To determine the influence of ethnic differences in diabetes care on inequalities
in mortality and prevalence of end-stage complications among diabetic patients. The …

Genetic variation, C-reactive protein levels, and incidence of diabetes

…, AG Uitterlinden, EJG Sijbrands, AH Bootsma… - …, 2007 - Am Diabetes Assoc
C-reactive protein (CRP) has been shown to be associated with type 2 diabetes, but whether
CRP has a causal role is not yet clear. We examined the association in the Rotterdam Study…

[PDF][PDF] Skin manifestations of diabetes

S Van Hattem, AH Bootsma, HB Thio - Cleve Clin J Med, 2008 - cdn.mdedge.com
Diabetes mellitus can be complicated by a variety of cutaneous manifestations. Good metabolic
control may prevent some of these manifestations and may support cure. Unfortunately, …

Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study

MT Schram, CG Schalkwijk, AH Bootsma, JH Fuller… - …, 2005 - Am Heart Assoc
We investigated the associations of pulse pressure (a measure of arterial stiffness) with the
early glycation products hemoglobin A1c (HbA1c) and Amadori albumin and the advanced …

Effect of losartan on microalbuminuria in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial

…, MGA Baggen, SWJ Lamberts, AH Bootsma… - Annals of Internal …, 2003 - acpjournals.org
Background: Angiotensin-converting enzyme inhibitors have shown antiproteinuric effects in
normotensive and hypertensive diabetic patients. Angiotensin-receptor antagonists reduce …

Ethnic differences in outcomes of diabetes care and the role of self-management behavior

LC Lanting, IMA Joung, I Vogel, AH Bootsma… - Patient Education and …, 2008 - Elsevier
OBJECTIVE: Ethnic differences in outcomes of outpatient diabetic care and the role of self-management
behavior and its determinants in explaining observed differences. METHODS: …

Atorvastatin Dose-Dependently Decreases Hepatic Lipase Activity in Type 2 Diabetes: Effect of sex and the LIPC promoter variant

…, RP Stolk, AH Bootsma, H Jansen… - Diabetes …, 2003 - Am Diabetes Assoc
OBJECTIVE—Hepatic lipase (HL) is involved in the metabolism of several lipoproteins and
may contribute to the atherogenic lipid profile in type 2 diabetes. Little is known about the …

Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides

…, IIL Berk-Planken, AH Bootsma, H Jansen… - Diabetes …, 2004 - Am Diabetes Assoc
OBJECTIVE—Apolipoprotein (apo)C-III is a constituent of HDL (HDL apoC-III) and of apoB-containing
lipoproteins (LpB:C-III). It slows the clearance of triglyceride-rich lipoproteins (TRLs…

[PDF][PDF] Change in urinary albumin excretion is predictive of cardiovascular outcome in normotensive patients with type 2 diabetes mellitus and microalbuminuria

…, RJTH Ouwendijk, MGA Baggen, AH Bootsma - Diabetes …, 2007 - research.rug.nl
RESEARCH DESIGN AND METHODS The present study is a prospective follow-up study of
67 normotensive patients (baseline blood pressure≤ 140/90 mmHg without …

Normotensive women with type 2 diabetes and microalbuminuria are at high risk for macrovascular disease

…, EJ Sijbrands, SW Lamberts, AH Bootsma - Diabetes …, 2006 - Am Diabetes Assoc
OBJECTIVE—The excess risk of macrovascular disease and death associated with diabetes
seems higher in women than in men. The pathogenesis for this risk difference has not been …